Description
A potent inhibitor of PLD, inhibiting human PLD1 and PLD2 in vitro (IC50 = 220 and 310 nM, respectively) and PLD activity in cells; inhibits the dopamine receptor
Formal name: N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide
Synonyms: NSC 354856|R34301
Molecular weight: 416.9
CAS: 59831-65-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis